Tebanicline dihydrochloride Ebanicline dihydrochloride; ABT-594 dihydrochloride|cas:209326-19-2|西域试剂

Tebanicline dihydrochloride Ebanicline dihydrochloride; ABT-594 dihydrochloride,98.91%

产品编号：Bellancom-14316A| CAS NO：209326-19-2| 分子式：C₉H₁₃Cl₃N₂O| 分子量：271.57

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用，

货号	价格	库存与货期
Bellancom-14316A	￥990.00	杭州北京（现货）
Bellancom-14316A	￥1550.00	杭州北京（现货）
Bellancom-14316A	￥3100.00	杭州北京（现货）
Bellancom-14316A	￥5200.00	杭州北京（现货）
Bellancom-14316A	￥8850.00	杭州北京（现货）

增值税发票√顺丰快递√订货电话：18601927057

Tebanicline dihydrochloride Ebanicline dihydrochloride; ABT-594 dihydrochloride

产品介绍

Tebanicline dihydrochloride (Ebanicline dihydrochloride) 是 nAChR 的调节物，具有有效的口服止痛活性。抑制 cytisine 与神经元 nAChR 的结合的 K_i 值为 37 pM。

生物活性

Tebanicline dihydrochloride (Ebanicline dihydrochloride) is a nAChR modulator with potent, orally effective analgesic activity. It inhibits the binding of cytisine to α4β2 neuronal nAChRs with a K_i of 37 pM.

体外研究

Tebanicline is a novel, potent cholinergic nAChR ligand with analgesic properties that shows preferential selectivity for neuronal nAChRs. It inhibits the binding of cytisine to α4β2 neuronal nAChRs with a K_i of 37 pM. Functionally, tebanicline is an agonist. At the transfected human α4β2 neuronal nAChR in K177 cells, with increased ⁸⁶Rb⁺ efflux as a measure of cation efflux, ABT-594 has an EC₅₀ value of 140 nM with an intrinsic activitycompared with (−)-nicotine of 130%; at the nAChR subtype expressed in IMR-32 cells, an EC₅₀ of 340 nM; at the F11 dorsal root ganglion cell line, an EC₅₀ of 1220 nM; and via direct measurement of ion currents, an EC₅₀ value of 56,000 nM at the human α7 homo-oligimeric nAChR produced in oocytes

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

Tebanicline is a potent antinociceptive agent with full efficacy in models of acute and persistent pain and that these effects are mediated predominately by an action at central neuronal nAChRs. Tebanicline produces significant antinociceptive effects in mice against both acute noxious thermal stimulation. ABT-594 is orally active, but 10-fold less potent by this route than after i.p. administration. The antinociceptive effect of ABT-594 is prevented, but not reversed, by the noncompetitive neuronal nicotinic acetylcholine receptor antagonist. Tebanicline has antinociceptive effects in rat models of acute thermal, persistent chemical, and neuropathic pain. Direct injection of tebanicline into the nucleus raphe magnus (NRM) is antinociceptive in a thermal threshold test and destruction of serotonergic neurons in the NRM attenuates the effect of systemic tebanicline^[4].

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

性状

Solid

溶解性数据

In Vitro:

H₂O : 100 mg/mL (368.23 mM; Need ultrasonic)

DMSO : ≥ 34 mg/mL (125.20 mM)

* "≥" means soluble, but saturation unknown.

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	3.6823 mL	18.4115 mL	36.8229 mL
5 mM	0.7365 mL	3.6823 mL	7.3646 mL
10 mM	0.3682 mL	1.8411 mL	3.6823 mL

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液，再依次添加助溶剂：

——为保证实验结果的可靠性，澄清的储备液可以根据储存条件，适当保存；体内实验的工作液，建议您现用现配，当天使用；以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比；如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的方式助溶

1.

请依序添加每种溶剂： PBS
Solubility: 25 mg/mL (92.06 mM); Clear solution; Need ultrasonic
2.

请依序添加每种溶剂： 10% DMSO 40% PEG300 5% Tween-80 45% saline
Solubility: ≥ 2.08 mg/mL (7.66 mM); Clear solution

此方案可获得 ≥ 2.08 mg/mL (7.66 mM，饱和度未知) 的澄清溶液。
以 1 mL 工作液为例，取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中，混合均匀；向上述体系中加入50 μL Tween-80，混合均匀；然后继续加入 450 μL生理盐水定容至 1 mL。
将 0.9 g 氯化钠，完全溶解于 100 mL ddH₂O 中，得到澄清透明的生理盐水溶液
3.

请依序添加每种溶剂： 10% DMSO 90% (20% SBE-β-CD in saline)
Solubility: ≥ 2.08 mg/mL (7.66 mM); Clear solution

此方案可获得 ≥ 2.08 mg/mL (7.66 mM，饱和度未知) 的澄清溶液。
以 1 mL 工作液为例，取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中，混合均匀。
将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中，再用生理盐水定容至 10 mL，完全溶解，澄清透明
4.

请依序添加每种溶剂： 10% DMSO 90% corn oil
Solubility: ≥ 2.08 mg/mL (7.66 mM); Clear solution

此方案可获得 ≥ 2.08 mg/mL (7.66 mM，饱和度未知) 的澄清溶液，此方案不适用于实验周期在半个月以上的实验。
以 1 mL 工作液为例，取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中，混合均匀。